Growth-Hormone Secretagogues as a Research Class

Growth-hormone secretagogue is a research-class label, not a single chemical family. It groups compounds by the target that preclinical studies have examined rather than by a shared backbone, which is why two materials in the same class can look very different on a certificate of analysis. This note describes what the label means, the two subtypes represented in the Advanced Sequence catalogue, and the documented identity fields that keep them apart.

What the class label describes

A secretagogue, read literally, is a substance that has been studied in the context of triggering a secretion. In the growth-hormone research literature the term is applied to compounds investigated for their interaction with two distinct receptor systems: the growth-hormone secretagogue receptor, historically associated with ghrelin-mimetic peptides, and the growth-hormone-releasing hormone receptor, associated with releasing-factor analogs. The important point for a laboratory is that the class name reports a research context, not an outcome. Grouping a material here says that literature has examined it against one of those targets, and nothing more. It does not assert that the compound raises, releases, or affects anything in any subject.

Because the grouping is functional rather than structural, the class spans more than one chemical design. Reading these materials well means treating the class as a filing category and then returning to the individual identity record for the chemistry that actually distinguishes one vial from another.

Two subtypes, two identity records

The catalogue represents the class with two peptides that sit in different subtypes. Only the fields documented for each are shown below; where a value such as a molecular formula or mass is not part of the supplied record, it is deliberately omitted rather than estimated.

Field	Ipamorelin	CJC-1295
Class descriptor	Pentapeptide secretagogue	Modified GRF analog
Sequence descriptor	5 amino acids	29-44 variants
CAS number	170851-70-4	863288-34-0
Reported purity	99.3%	99.1%
Catalogue sizes	5 mg, 10 mg	2 mg, 5 mg

Ipamorelin is documented as a pentapeptide, a five-residue secretagogue in the ghrelin-mimetic subtype. Its record stops at a class and a residue count, so a responsible write-up stops there too and does not attach a full residue string pulled from memory. CJC-1295 is documented as a modified growth-hormone-releasing-factor analog referencing the 29-44 region, a different design that belongs to the releasing-factor subtype. The two share a research class and almost nothing else on paper, which is exactly why the class label alone is never enough to confirm what is in a vial.

Why the CAS number carries the weight

Since the subtypes differ in structure, the CAS registry number is the field that most reliably separates them. A shared class name can appear on unrelated preparations, but the registry number is a stable, unique handle for a defined substance. Confirming 170851-70-4 for one material and 863288-34-0 for the other is a firmer check than matching the words secretagogue or analog, which can travel loosely across catalogues.

The two subtypes are also documented at different levels of structural detail, and a careful record respects that. Ipamorelin’s supplied data stops at a pentapeptide class and a five-residue count, so a defensible write-up cites exactly those fields and no invented residue string or mass. CJC-1295’s record references the 29-44 region of a modified releasing factor and a set of documented variants, which is a different kind of descriptor entirely. Reading the two side by side is a useful reminder that within a single research class the available identity information is not uniform, and that the correct response to a missing field is to leave it out rather than to fill it from a similar-looking compound elsewhere in the catalogue.

How the class is studied, described neutrally

Research interest in this class has centred on receptor-level interactions examined in vitro and in defined preclinical models. The honest register for describing that work is attributive and past-referential: a compound has been investigated in the context of a receptor system, or research has characterised its binding behaviour under stated assay conditions. That phrasing reports what was measured without asserting an effect. For the methodology behind those measurements, the note on how receptor-binding assays are used in peptide research covers the formats and their limits, and the wider compound classes archive places this group alongside the others.

What the class framing must never become is a benefit claim. The presence of a target in the literature is not evidence of an outcome, and a laboratory documenting these materials should keep the distinction visible in its own records and labelling.

Handling and catalogue notes

Both materials are supplied as research-use-only reference compounds. As lyophilized peptides they are handled cold and dry and protected from light and moisture; general storage practice for freeze-dried solids is covered separately and does not include preparation amounts, concentrations, schedules, or routes, which fall outside a class overview. Product-level identity records for Ipamorelin and CJC-1295 list the documented fields for each, and the full catalogue is reachable from the shop.

Read this way, the class is a useful first filter and a poor final answer. It tells a researcher which shelf a material belongs on and which literature to consult, but the vial-level decision, the one that determines what actually goes into an experiment, always returns to the registry number, the sequence descriptor, the reported purity, and the certificate that should accompany the lot. A class label that is treated as a shortcut past those fields is precisely where documentation errors begin.

Common questions

What makes a compound a growth-hormone secretagogue?

It is a research-class label for compounds studied against the growth-hormone secretagogue receptor or the growth-hormone-releasing hormone receptor. The grouping reports a research context, not an outcome, and covers more than one chemical design.

Are Ipamorelin and CJC-1295 the same kind of peptide?

No. Ipamorelin is documented as a five-residue pentapeptide secretagogue; CJC-1295 is a modified growth-hormone-releasing-factor analog referencing the 29-44 region. They share a research class but differ in structure, so their CAS numbers are the reliable way to tell them apart.

Does the class label imply the compounds work?

No. The label only indicates the receptor context that literature has examined. It is not evidence of any effect, and these materials are supplied strictly for laboratory research use.

References

Repair and Regenerative Peptides: A Class Overview

Repair and regenerative peptide is a descriptive research grouping that collects compounds studied in tissue-related preclinical models. Like any class label it reports a research context rather than an effect, and the compounds inside it are chemically distinct. This overview uses BPC-157 and TB-500 as documented examples, shows the identity fields that separate them, and keeps the framing where it belongs, on what has been studied rather than on what any material does.

What the grouping means, and what it does not

The label gathers materials whose literature has examined processes associated with tissue maintenance and remodelling in laboratory systems. That is a filing convenience for researchers scanning for relevant work, not a statement of outcome. Nothing about membership in this class asserts that a compound heals, repairs, or regenerates anything in any subject; the grouping simply signals the research area in which a material has appeared. Holding that line matters more here than in most classes, because the words repair and regenerative carry an obvious pull toward benefit language that the underlying preclinical data does not support.

The two examples below sit in the class for different reasons. One is a synthetic pentadecapeptide with a fully specified structure; the other is a fragment of a naturally occurring protein documented at the fragment level. Their identity records reflect that difference.

Two documented examples

For BPC-157 the supplied record includes verified structural identifiers, so they are shown. For TB-500 the record documents class, sequence descriptor, CAS number, and purity only, and no molecular formula or mass is stated because none is part of the supplied data.

Field	BPC-157	TB-500
Class descriptor	Gastric pentadecapeptide	Thymosin beta-4 fragment
Sequence descriptor	15 amino acids	Actin-regulating fragment
CAS number	137525-51-0	77591-33-4
Molecular formula	C62H98N16O22	Not stated in record
Molecular weight	1419.5 g/mol	Not stated in record
Reported purity	99.9%	99.4%
Catalogue sizes	5 mg, 10 mg	5 mg, 10 mg

BPC-157 is a synthetic 15-residue peptide, documented in public registries with the formula C62H98N16O22 and a calculated mass of 1419.5 g/mol. TB-500 is documented as an actin-regulating fragment of thymosin beta-4; its honest descriptor is the fragment name, and inventing a full sequence or a formula for it would be exactly the kind of fabricated identifier a careful record avoids. The contrast is the lesson: two members of one class can carry very different amounts of documented structural detail, and a certificate should be read for what it actually states rather than for what the class name implies.

Research framing for each

Research interest in BPC-157 has centred on preclinical tissue models, and interest in TB-500 has centred on actin dynamics and related cell-level processes described in the literature. Both statements are attributive and bounded to the studies that made them; neither asserts an outcome. For the methodology that underlies such work, the note on in vitro and in vivo models explains how these systems are built and what their results can and cannot support.

The limits of a functional grouping

Because repair and regenerative describes a research area rather than a mechanism, the boundary of the class is soft. A compound can appear in tissue-related preclinical literature for reasons that have little to do with any shared pathway, and two materials filed together here may have been studied in entirely different model systems. That softness is not a flaw in the label so much as a caution about how far to lean on it. The grouping earns its place as a way to locate relevant reading; it does not license the inference that members behave alike, and it certainly does not license the leap from a preclinical observation in one model to a general statement about what a compound accomplishes.

A related subtlety is the counterion question that a class overview can easily gloss. A peptide supplied as a salt carries a counterion whose mass is not part of the residue chain, so the net peptide content of a lot can differ from the gross powder mass. This is a per-lot, per-certificate matter rather than a class property, which is another reason the grouping cannot substitute for the individual identity record and the certificate that accompanies a specific batch.

Reading the class without overreaching

A defensible way to use this grouping is to treat it as a pointer to a body of preclinical literature and then verify each material at the vial level. Confirm the CAS number, check that the class and sequence descriptors are internally consistent, and treat the reported purity as a lot-specific figure to be checked against a certificate. The example purities above, like all such figures, should be read as illustrative of the fields a certificate carries rather than as a specific lot a reader can order today; a real certificate of analysis documents the tested value for the material in hand.

Product-level records for BPC-157 and TB-500 list the documented fields for each, example test data can be reviewed under lab results, and the grouping sits alongside the others in the compound classes archive. Used this way, repair and regenerative stays what it should be: a neutral research category, not a promise.

The habit worth carrying away is to let the class do only the work it can do. It points to a body of preclinical literature and puts two structurally different materials on the same shelf for convenience. It does not confirm identity, it does not quantify quality, and it does not describe an outcome. Each of those jobs belongs to a different part of the record: the registry number and structural fields for identity, the certificate for quality, and the primary literature, read in the neutral register described elsewhere in these notes, for what has actually been studied. A researcher who keeps those jobs separate can use the class label freely without ever being misled by it.

Common questions

Does the repair and regenerative label mean these peptides repair tissue?

No. It is a descriptive research grouping for compounds studied in tissue-related preclinical models. It reports a research context, not an outcome, and these materials are supplied for laboratory research use only.

Why does BPC-157 have a formula listed but TB-500 does not?

BPC-157 is a synthetic peptide with verified public-registry identifiers, including the formula C62H98N16O22. TB-500 is documented only as an actin-regulating thymosin beta-4 fragment, so no formula is stated rather than one being invented.

How should the purity figures be interpreted?

As illustrative of the fields a certificate carries, not as a specific purchasable lot. A real certificate of analysis reports the tested purity for the actual material received.

References

Cellular-Aging Research Compounds: NAD+, Epithalon, MOTS-c

Cellular-aging research compound is one of the loosest class labels in a peptide catalogue, because it groups materials by the research area they appear in rather than by any shared chemistry. The three examples here, a dinucleotide coenzyme, a short pineal-derived tetrapeptide, and a mitochondria-derived peptide, have almost nothing structurally in common. This note explains what the grouping does and does not mean and shows only the identity fields documented for each.

A grouping by research context, not structure

These materials are collected because literature has examined them in the context of cellular-aging research, a broad area covering processes studied in cell and preclinical models. The label is a pointer to that literature. It is emphatically not a claim that any of these compounds slows, reverses, or affects aging in any subject, and the marketing-adjacent language that often surrounds this category is exactly what a research write-up must avoid. The responsible register is attributive: a compound has been investigated in the context of a pathway or process, and research interest has centred on a particular question. That reports the study without asserting the result.

Because the three are chemically unrelated, the class is useful only as a first filter. Every meaningful decision returns to the individual identity record.

Three distinct identity records

Only documented fields are shown. NAD+ has a molecular formula in its supplied record and it is included; for Epithalon and MOTS-c no formula or mass is part of the record, so none is stated.

Field	NAD+	Epithalon	MOTS-c
Class descriptor	Dinucleotide coenzyme	Pineal-derived tetrapeptide	Mitochondria-derived peptide
Sequence descriptor	Coenzyme, not a peptide chain	Ala-Glu-Asp-Gly	16 amino acids
Molecular formula	C21H27N7O14P2 (as supplied)	Not stated in record	Not stated in record
CAS number	53-84-9	307297-39-8	1627580-64-6
Reported purity	99.0%	99.5%	99.2%
Catalogue sizes	100 mg, 500 mg	10 mg, 50 mg	10 mg, 25 mg

NAD+ is a coenzyme rather than a peptide, which is why its sequence field is not a residue string; its supplied record includes the formula C21H27N7O14P2. Epithalon is documented as a four-residue tetrapeptide with the sequence Ala-Glu-Asp-Gly. MOTS-c is documented as a sixteen-residue mitochondria-derived peptide, and because no full residue string is supplied, the honest descriptor stops at the residue count and the class. The single table makes the diversity plain: one small molecule coenzyme and two peptides of very different lengths, sharing a research heading and little else.

Why the differences matter at receiving

A shared class heading can mask the fact that these materials are checked against different reference data. NAD+ can be cross-checked against its formula and CAS number; Epithalon against its short, fully specified sequence and CAS number; MOTS-c against its residue count, class, and CAS number. Treating them identically because they share a shelf is how a mismatch slips through. The CAS number is the common anchor that works across all three.

Chemical diversity within one heading

It is worth dwelling on just how different these three materials are, because the shared label can flatten that in a reader’s mind. NAD+ is a small-molecule coenzyme built from two nucleotides; it is not a peptide at all, and describing it with a residue sequence would be a category error. Epithalon is a genuine peptide, but a very short one, four residues fully specified as Ala-Glu-Asp-Gly, which means its entire primary structure fits in a single line and can be confirmed directly. MOTS-c is a peptide roughly four times that length, documented at sixteen residues, where the supplied record gives a count and a class rather than a spelled-out chain. Three materials, three completely different identity footprints, one research heading.

The documentation discipline that follows is simple to state and easy to violate under time pressure. Cite the fields that are supplied, in the form they are supplied, and leave blank what is not. For NAD+ that includes the formula C21H27N7O14P2 as given; for Epithalon it includes the full tetrapeptide sequence; for MOTS-c it stops at the residue count and class. Resisting the urge to complete a record from a plausible-looking source is the single habit that keeps a cellular-aging inventory defensible, precisely because this is a category where confident, under-sourced claims are common in the surrounding literature.

Handling and neutral framing

All three are supplied as research-use-only reference materials in lyophilized form and are handled cold and dry, protected from light and moisture. As with every class overview, this note carries no preparation amounts, concentrations, schedules, or routes. The point of the grouping is to help a researcher locate relevant preclinical literature, then to hand the decision back to the identity record and the certificate. For the underlying methodology, the note on interpreting mechanism-of-action literature explains how to keep observations separate from the interpretation and extrapolation that often inflate reports in this exact category.

Product-level records for NAD+, Epithalon, and MOTS-c list each material’s documented fields, and the grouping sits with the others in the compound classes archive. Read with that discipline, cellular-aging research compound stays a neutral filing category rather than a claim about what any of these materials can do.

The broader lesson generalises past these three. Any class heading that names a research area rather than a mechanism will collect materials that differ more than they resemble one another, and the more evocative the heading, the more careful a write-up has to be. Cellular aging is about as evocative as these headings get, which is exactly why the surrounding literature is dense with confident restatements that outrun their sources. The defensible posture is unglamorous and consistent: describe what was studied, in whose model, at what level of documentation, and hand every vial-level decision back to the identity record and the certificate. That posture is what lets a laboratory work in this category at all without importing claims it cannot support.

Common questions

Do these compounds slow or reverse aging?

No such claim is made or implied. The label groups materials that literature has examined in cellular-aging research contexts. It is a pointer to that research area only, and these compounds are supplied strictly for laboratory research use.

Why is NAD+ grouped with two peptides?

The grouping is by research context, not chemistry. NAD+ is a dinucleotide coenzyme, Epithalon is a tetrapeptide, and MOTS-c is a sixteen-residue peptide. They share a research heading while differing completely in structure.

What identifies MOTS-c if no formula is listed?

Its documented record covers the class descriptor, a sixteen amino acid sequence descriptor, the CAS number 1627580-64-6, and reported purity. No molecular formula is stated because none is part of the supplied data.